Time course of disaster-related cardiovascular disease and blood pressure elevation

Keisuke Narita; Satoshi Hoshide; Kazuomi Kario

doi:10.1038/s41440-021-00698-y

Time course of disaster-related cardiovascular disease and blood pressure elevation

Keisuke Narita
, Satoshi Hoshide
, Kazuomi Kario

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Original language	English
Pages (from-to)	1534-1539
Number of pages	6
Journal	Hypertension Research
Volume	44
Issue number	11
DOIs	https://doi.org/10.1038/s41440-021-00698-y
State	Published - Nov 2021
Externally published	Yes

Access to Document

10.1038/s41440-021-00698-y

Cite this

@article{4fb99690fbf644918a6c6334b1bd83b8,

title = "Time course of disaster-related cardiovascular disease and blood pressure elevation",

author = "Keisuke Narita and Satoshi Hoshide and Kazuomi Kario",

note = "Funding Information: Conflict of interest KK has received research funding from Teijin Pharma Limited, Omron Healthcare Co., Fukuda Denshi, Bayer Yakuhin Ltd., A\&D Co., Daiichi Sankyo Co., Mochida Pharmaceutical Co., EA Pharma, Boehringer Ingelheim Japan Inc., Tanabe Mit-subishi Pharma Corp., Shionogi \& Co., MSD K.K., Sanwa Kagaku Kenkyusho Co., and Bristol-Myers Squibb KK, and honoraria from Takeda Pharmaceutical Co. and Omron Healthcare Co.",

year = "2021",

month = nov,

doi = "10.1038/s41440-021-00698-y",

language = "English",

volume = "44",

pages = "1534--1539",

journal = "Hypertension Research",

issn = "0916-9636",

publisher = "Springer Nature",

number = "11",

}

TY - JOUR

T1 - Time course of disaster-related cardiovascular disease and blood pressure elevation

AU - Narita, Keisuke

AU - Hoshide, Satoshi

AU - Kario, Kazuomi

N1 - Funding Information: Conflict of interest KK has received research funding from Teijin Pharma Limited, Omron Healthcare Co., Fukuda Denshi, Bayer Yakuhin Ltd., A&D Co., Daiichi Sankyo Co., Mochida Pharmaceutical Co., EA Pharma, Boehringer Ingelheim Japan Inc., Tanabe Mit-subishi Pharma Corp., Shionogi & Co., MSD K.K., Sanwa Kagaku Kenkyusho Co., and Bristol-Myers Squibb KK, and honoraria from Takeda Pharmaceutical Co. and Omron Healthcare Co.

PY - 2021/11

Y1 - 2021/11

UR - https://www.scopus.com/pages/publications/85112336242

U2 - 10.1038/s41440-021-00698-y

DO - 10.1038/s41440-021-00698-y

M3 - Comment/debate

C2 - 34381195

AN - SCOPUS:85112336242

SN - 0916-9636

VL - 44

SP - 1534

EP - 1539

JO - Hypertension Research

JF - Hypertension Research

IS - 11

ER -